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Introduction: High doses of activity-based rehabilitation therapy improve outcomes
after stroke, but many patients do not receive this for various reasons such as poor
access, transportation difficulties, and low compliance. Home-based telerehabilitation
(TR) can address these issues. The current study evaluated the feasibility of an expanded
TR program.
Methods: Under the supervision of a licensed therapist, adults with stroke and limb
weakness received home-based TR (1 h/day, 6 days/week) delivered using games and
exercises. New features examined include extending therapy to 12 weeks duration,
treating both arm and legmotor deficits, patient assessments performedwith no therapist
supervision, adding sensors to real objects, ingesting a daily experimental (placebo) pill,
and generating automated actionable reports.
Results: Enrollees (n = 13) were median age 61 (IQR 52–65.5), and 129 (52–486) days
post-stroke. Patients initiated therapy on 79.9% of assigned days and completed therapy
on 65.7% of days; median therapy dose was 50.4 (33.3–56.7) h. Non-compliance
doubled during weeks 7–12. Modified Rankin scores improved in 6/13 patients, 3 of
whom were >3 months post-stroke. Fugl-Meyer motor scores increased by 6 (2.5–12.5)
points in the arm and 1 (−0.5 to 5) point in the leg. Assessments spanning numerous
dimensions of stroke outcomes were successfully implemented; some, including a
weekly measure that documented a decline in fatigue (p = 0.004), were successfully
scored without therapist supervision. Using data from an attached sensor, real objects
could be used to drive game play. The experimental pill was taken on 90.9% of therapy
days. Automatic actionable reports reliably notified study personnel when critical values
were reached.
Conclusions: Several new features performed well, and useful insights were obtained
for those that did not. A home-based telehealth system supports a holistic approach to
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rehabilitation care, including intensive rehabilitation therapy, secondary stroke prevention,
screening for complications of stroke, and daily ingestion of a pill. This feasibility study
informs future efforts to expand stroke TR.
Clinical Trial Registration: Clinicaltrials.gov, # NCT03460587.
Keywords: stroke, telehealth, recovery, rehabilitation, holistic
INTRODUCTION
Stroke is perennially among the leading causes of human
disability (1, 2) and the leading neurological cause of lost
disability-adjusted life years (3). The number of affected people
has doubled over the past two decades (4), partly because of
the aging population (5) and partly because advances in stroke
medicine have increased the fraction of patients surviving acute
stroke (6). Motor deficits, present in>80% of patients with stroke
acutely, are a major contributor to this disability. Few patients
recover completely, with 55–75% having enduring motor deficits
(7, 8). At 6 months post-stroke, 65% of patients are unable
to incorporate the paretic hand effectively into daily activities
(9). Persistent arm impairment is linked with greater activity
limitations, higher participation restrictions, poorer quality of
life, and reduced well-being (10–12).
There is strong evidence that higher doses of rehabilitation
therapy are associated with greater behavioral gains, especially for
paretic arm function after stroke (13–18), even with variability
in treatment content and definition of dose (19). This remains
true when higher therapy doses are delivered in the home
(14, 20). However, patients generally do not receive high doses
of rehabilitation therapies, due to cost, traveling difficulties,
and regional shortages of rehabilitation providers–factors that
are exacerbated in the COVID-19 era. Quality of rehabilitation
therapy is also important and can increase the extent to which
clinical neuroplasticity is harnessed (21): effects are higher when
therapy is challenging, motivating, and engaging (22–25).
Telehealth might be able to help by increasing access
to high quality therapy (26). Telerehabilitation (TR) has
been defined as the delivery of rehabilitation services via
communication technologies and encompasses a range of
rehabilitation and habilitation services that include evaluation,
assessment, monitoring, prevention, intervention, supervision,
education, consultation and coaching (27). This is similar
to the holistic framework outlined by Demiris et al. (28),
who suggested that home-based post-stroke TR should include
support that spans an array of medical, mental health, and
social services. Compared to traditional in-clinic therapy, TR
uses the same principles of individualized care by a licensed
therapist. This telehealth approach provides enhanced options
compared to delivery of rehabilitation services using a brick-and-
mortar approach (29–33), potentially decreasing transportation
needs for patients with functional limitations, boosting physical
activity, and expanding access to care.
Telehealth can also help by increasing motivation and
compliance. The technological underpinnings of TR can facilitate
a personalized approach to upper extremity (UE) motor
rehabilitation (34). Telehealth can deliver therapy in the form
of games, an approach known to promote patient participation
in health care (35–39). Games motivate patients to engage in
enjoyable play behavior that involves therapeutically relevant
movements (40, 41), which is important because patient
compliance with stroke rehabilitation is often limited (42–44).
The overall experience with motor TR after stroke is mixed.
While one review found that all 18 studies of post-stroke motor
TR improved disability (32), a recent meta-analysis concluded
that drawing general conclusions about the effects of stroke TR is
difficult, as interventions and comparators varied greatly across
studies (45). We have completed three trials of TR targeting
arm motor deficits after stroke. The first was a pilot study (46)
that provided 12 patients with chronic stroke with 4 weeks
of home-based, therapist-supervised TR. Findings included
that patients were highly compliant (97.9% of assigned days),
videoconferences supported regular communication between the
patient at home and therapists in the clinic, arm motor status
improved significantly based on the UE Fugl-Meyer (UE-FM)
motor scale, and no computer skills were needed, as computer
literacy was not related to usage or treatment gains. With 60
min/day of TR, patients averaged 879 arm repetitions/day. A
second study found that eight sessions of visuomotor training in
the home improved visuomotor tracking by the UE (47).
More recently we led an 11-site, randomized, assessor-blind
trial of TR (48). A total of 124 patients with stroke were
randomized to receive 36 sessions of 70-min duration, either
in-clinic or in the home via TR. In the 62 patients randomized
to TR, UE-FM scores increased by 7.9 ± 6.7 points, and TR
was found to be non-inferior to in-clinic therapy. Motor gains
remained significant when patients enrolled >90 days post-
stroke were examined separately. Gains were also significant
when examining change in Box & Blocks score, a measure of
arm function (activities limitation). In a separate manuscript
under review, we found that 39.5% of patients randomized to
TR and enrolled >90 days post-stroke showed reduced global
disability (improved mRS score); in contrast, natural history data
indicate that mRS scores generally plateau by day 90 (49, 50),
suggesting that TR benefits might generalize to improved global
functional outcomes.
The purpose of the current study was to evaluate the feasibility
of several expansions to our prior TR program, in two main
ways, treatment and assessment. Treatment topics were extension
of daily TR from 6 to 12 weeks; incorporation of therapy
targeting the lower extremity (LE), in addition to UE therapy;
incorporation of augmented reality (AR) into this TR system;
introduction of games that use a real object to train instrumental
activities of daily living (iADLs); and addition of a daily study
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TABLE 1 | Entry criteria.
Inclusion criteria
1. Age ≥18 years at the time of randomization
2. Stroke that is radiologically verified, with any time of stroke onset prior
to randomization
3. Upper extremity motor Fugl Meyer (UE-FM) score of 28–66 out of 66; to insure
some deficit is present, if UE-FM > 59, must also have Box & Blocks (B&B)
score on affected side >25% lower than on non-affected side
4. Box & Block Test score with affected arm is at least 3 blocks in 60 s at the
first visit
5. Informed consent and behavioral contract signed by the subject
Exclusion criteria
1. A major, active, coexistent neurological or psychiatric disease, including
alcoholism or dementia
2. A diagnosis (apart from the index stroke) that substantially affects paretic
arm function
3. A major medical disorder that substantially reduces the likelihood that a subject
will be able to comply with all study procedures
4. Severe depression, defined as Geriatric Depression Scale Score > 11 out
of 15
5. Significant cognitive impairment, defined as Montreal Cognitive Assessment
score< 22; this can be waived at the discretion of the study PI, e.g., for aphasia
6. Deficits in communication that interfere with reasonable study participation
7. Lacking visual acuity, with or without corrective lens, of 20/40 or better in at
least one eye
8. Life expectancy < 6 months
9. Receipt of Botox to arms, legs, or trunk in the preceding 6 months, or
expectation that Botox will be administered to the arm, leg, or trunk prior to
completion of participation in this study
10. Unable to successfully perform all 3 of the rehabilitation exercise
test examples
11. Unable or unwilling to perform study procedures/therapy, or expectation of
non-compliance with study procedures/therapy, or expectation that subject
will be unable to participate in study visits
12. Concurrent enrollment in another investigational study
13. Subject does not speak sufficient English to comply with study procedures
14. Expectation that subject will not have a single domicile address during the
12 weeks of therapy, within 75 miles of the central study site
pill to be taken at the start of TR, a feature that might improve
secondary stroke prevention and also might facilitate clinical
trials of restorative therapies that are administered in pill form.
Assessment topics included addition of tests performed by the
patient using the TR system independently, with no therapist
present; validation of telehealth screening for depression and
aphasia; and generation of actionable email reports to clinicians
whenever a critical finding occurred. The feasibility of each of
these expansions was examined.
METHODS
Study Overview
In this prospective, single-group, therapeutic feasibility trial,
patients underwent live assessment at the UC Irvine clinic twice
at baseline, after which a telehealth system was delivered to the
patient’s home. Patients then received 12 weeks of TR therapy, 6
days/week, with a live clinic assessment at the end of week 6 and
week 12. Patients were free to call the lab with questions. This
study was approved by the UC Irvine IRB, and was registered as
clinicaltrials.gov ID # NCT03460587.
Participants
Patients were recruited from the community through local
advertisements. In sum, enrollees were adults with arm paresis
due to stroke and no limiting cognitive deficits. Full entry
criteria appear in Table 1. Patients signed informed consent (no
surrogate consent) and were evaluated for eligibility at the first
two visits.
Study Intervention
After all eligibility criteria were confirmed, the patient signed a
behavioral contract (51) that listed a personal treatment goal and
the time when therapy would begin each day. An initial treatment
plan was created by a licensed occupational therapist (OT) or
physical therapist (PT), standardized by use of an algorithm that
uses the 33 UE-FM sub-scores to identify the three greatest UE
impairments. The algorithm suggests games and exercises that
are matched to these three impairments and so calibrates initial
TR games and exercises to each patient’s impairment level.
Patients were provided 72 treatment sessions, 6/week for 12
weeks. Each session was 60min in duration and consisted of least
15min of functional games, at least 15min of exercises, and 5min
of stroke education using a Jeopardy style game.
There were 12 input devices used by patients to interact
with the TR system: a PlayStation Eye camera, motion game
controller (PlayStationMove, Sony; Tokyo, Japan), joystick, small
buttons (10), large buttons (4), toy pistol holding a Wii remote
(Nintendo; Kyoto, Japan) with corresponding IR sensor bar,
trackpad (Logitech; Newark, CA), grip force cylinder, pinch force
cube, rotating shuttle wheel (Powermate, Griffin Technology;
Nashville, TN), steering wheel with gas/brake, and a 9-DOF IMU
containing a 3-axis accelerometer, gyroscope, andmagnetometer.
A total of 114 exercises were available, targeting UE, LE,
and trunk. Each was 1–5min long and consisted of a video
showing the assigned movement. Patients were instructed to
move as in the video. Therapists had the option to incorporate
standard equipment (e.g., resistance bands; Theraband; Akron
OH) provided to patients at the time the TR system was delivered
to the home, to be used while watching the exercise videos.
A total of 33 functional games were also available, each 1–
5min long. These stress motor control features, e.g., varying
movement speed, range of motion, target size, extent of
visuomotor tracking, or level of cognitive demand. Game features
were selected and adjusted by the therapist. For example, during
the whack-a-mole game, higher difficulty level means a broader
area where targets can appear on the tabletop and less time to
successfully hit the target. Therapists also select which input
device the patient will use for game play, based on UE status, e.g.,
the flappy-bird game can be played using the grip force cylinder,
pinch force cube, or trackpad.
Therapists also decided whether five photographs would be
taken at random time points during a given game, to gain insights
into how the patient was playing the game. After the day’s 1-h of
assignments were completed, patients were allowed to free play,
i.e., to use the system to play functional games ad libitum.
Stroke education targeted five categories (Stroke Risk Factors,
Stroke Prevention, Effects of Stroke, Diet, and Exercise) focused
on secondary prevention. Patients made armmovements to enter
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their answers to multiple-choice questions, delivered via a video
Jeopardy game format [an approach known to foster learning
(52, 53)], and then received feedback on their answers.
To build each day’s treatment session, therapists used a
graphical interface to drag treatment elements into a 60-min
planner for each day’s session; they then adjusted the challenge
level (games) and the duration (games and exercises), and
selected which input device would be used to drive gameplay
(games). The daily treatment plan was regularly updated by a
therapist based on findings from videoconferences and from
review of TR-based data. Four types of TR-based patient data
were automatically transmitted from home to lab, in real time:
system usage (time TR was used), patient performance (game
scores), behavioral status (assessment scores), and photographs
(during games and pill consumption).
Patients had 18 HIPAA-compliant videoconferences (VSee
software; VSee; Sunnyvale, CA) with a licensed therapist: three
times/week during weeks 1–2, two times/week during weeks 3–4,
and one time/week during weeks 5–12. During videoconferences,
questions were answered, feedback was provided, progress was
reviewed, and on some days remote assessments were made.
During the 30min prior to the TR session, the computer
alerted the subject that the start time was coming soon. The
subject hit a large tabletop button to begin the day’s session and
to start subsequent games/exercises after each one is completed.
In this way, patients could take a break between games/exercises.
Unsupervised sessions had the same treatment content as
supervised sessions, but no therapist contact.
Novel TR Features Evaluated
Key novel features added to the TR system and evaluated
included the following:
(1) Lower extremity games and exercises: Our prior three TR
studies (46–48) were focused exclusively on UE therapy.
Here we also targeted the paretic LE, introducing LE exercise
videos, LE driving games, and the AR “virtual varmint”
game. In the driving games, patients used a steering wheel
and gas/brake pedals to navigate a virtual terrain.
(2) Augmented reality (AR) gaming: With an AR-based
approach, subjects interact in the real-world workspace with
virtual computer-generated objects (47, 54, 55). This was
used in the Virtual Varmint game, where subjects looked
at a tabletop monitor that showed a real-time video display
of their paretic foot; a virtual gopher was projected into
this display, and when the subject’s foot overlapped with
the gopher, points were earned. A camera was placed under
the table and pointed at the paretic foot. The TR computer
displayed camera output on the tabletop monitor along with
a computer-generated varmint (a gopher). Patients looking
at the tabletop monitor thus used real-time images of their
foot movements to manipulate a virtual varmint.
(3) Use of real objects to drive gameplay targeting Instrumental
Activities of Daily Living (iADL): The TR accelerometer had
a magnet and was attached to a lemonade pitcher by the
patient prior to starting the game. Accelerometer data were
sent to the TR computer. As the subject used the paretic
arm to rotate the pitcher, a figure of a pitcher on the video
screen moved synchronously, allowing the subject to use a
real object to play a game where the goal was to fill empty
cups to the correct level.
(4) Daily study pill consumption: Each day, patients were also
asked to consume a study pill. This pill was an unblinded
placebo (small sugar-freemint). The computer screen guided
patients through a series of steps to open the pill container,
put the lid on the TR table, put a pill in their hand, ingest the
pill, and then replace the lid; the TR camera took a picture
when the patient hit a button to indicate that each step was
completed, and these pictures were later used to confirmed
compliance with pill intake. Pills were kept in a yellow
container, clipped to the TR table, and had a lid (DoseSmart;
RxCap; Boston, MA) that sent a Bluetooth signal to the
computer each time the container was opened.
(5) Expanded assessments, as below.
(6) E-mail actionable reports for critical findings: The study
coordinator and lead investigator were automatically sent an
email (with a suggested response) if either of two conditions
arose: (1) sharp increase in pain, defined as increase in the
shoulder pain score by≥20/100, with the suggested response
being to contact the patient same day; (2) non-compliance
with therapy, defined as the patient failing to initiate TR for
3 days in a row, with the suggested response being to contact
the patient same day.
(7) Reliance on home WiFi: In addition, we sought to evaluate
the performance of each patient’s home WiFi network. In
each case, the home-based TR system was connected to the
internet using the patient’s personal wireless network rather
than a study-provided wireless cellular modem.
Study Assessments
To fully characterize enrollees, a broad range of assessments
was evaluated, including measures of impairment, activities
limitation, quality of life, and patient-reported measures. In
addition to assessments at the four in-clinic visits, patients
underwent assessments at home via the TR system, some of
which were supervised by therapists and some scored with no
therapist present.
The primary endpoint was the UE-FM scale (56, 57), which
ranges from 0 to 66, with higher scores indicating less UE
impairment. The main secondary endpoint for UE was the
Box & Blocks (B&B) score (58), which counts the number of
blocks a subject can lift and move across the table in 60 s. The
two main LE secondary endpoints 10 meter walk test of gait
velocity (59) (measured as the mean of two trials) and the LE-
FMmotor scale (56, 57), which ranges from 0 to 34, which higher
scores indicating less LE impairment. Demographic data, medical
history, and handedness (60) were obtained on study entry. The
presence of aphasia was assessed using Philadelphia Naming Test
(Form A) (61). The presence of neglect was assessed using the
Line Cancellation Test (62).
A social network survey (PERSNET) was assessed during
the live visit 6 weeks after enrollment. The results of these
social network studies are presented in a separate companion
paper (63).
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Several additional dimensions of stroke outcome were
measured at baseline and after 12 weeks of therapy: Optimization
in Primary and Secondary Control (OPS) scale (64), which
measures dedication to treatment goals across 12 questions,
with scores ranging from 1 to 7 and higher scores reflecting
greater motivation; Nottingham sensory scale (65), which
assesses a range of sensory modalities in the distal UE, with
maximum score of 11 and higher scores reflecting better sensory
function; Geriatric Depression Scale (GDS) (66), which measures
depression across 15 questions, with a maximum score of
15 and higher scores reflecting greater depression; Montreal
Cognitive Assessment (MoCA) (67), which measures cognitive
function, with maximum score of 30 and higher scores reflecting
less cognitive impairment; modified Rankin Scale (mRS) (68),
which measures global function (disability and dependence),
with a maximum score of 6 and higher scores reflecting poorer
function; EuroQol visual analog scale (EQ-VAS) (69), in which
a subject rates his/her own health from 0 to 100 and higher
scores reflect better quality of life; and modified Ashworth
Spasticity (mAS) scale (70), which measures spasticity at the
elbow flexor, with a maximum score of 4 and higher scores
reflecting greater spasticity.
Some assessments were made by the study therapist using the
TR system. Patient-reported outcomes, which are well aligned
with scoring via videoconference, were examined. Hand function
was measured using the Stroke Impact Scale (71) (SIS)-hand
subsection, with a maximum score of 5 and higher scores
reflecting better hand usage. This patient-reported outcome
was measured during videoconferences in weeks 1 and in 12.
Functional status was measured using the SIS-activity of daily
living (ADL) subsection (71) during videoconferences in weeks
2 and in 12; the maximum score is 5, and higher scores reflect
less difficulty with ADLs.
Other assessments were made by the patient, with no therapist
present, using the TR system. To maximize the likelihood that
the unsupervised patient at home would be successfully assessed,
the focus here was on Likert scales and visual analog scales.
The MOS Social Support Survey (72) (MOS-SSS) was scored
via the TR system during week 2; scores range from 19 to 95,
with higher scores reflecting stronger social support. The Brief
Resilience Scale (73) was also scored via the TR system during
week 4; maximum score is 30, with higher scores indicating better
resilience. The Generalized Anxiety Disorder-7 (74) (GAD-7)
scale was also scored via the TR system in week 3; maximum
score is 21, with higher scores reflecting greater anxiety. Finally,
shoulder pain and fatigue were assessed weekly with a focus on
the first 6 weeks, using a visual analog scale (0–100) where higher
numbers indicate greater pain and fatigue, respectively.
Some assessments were scored by the therapist at both a
live visit and during a TR videoconference, in order to validate
telehealth screening. Measures of mood and language were
selected given the expectation that patients would likely be
stable in these domains across the 1–3 weeks when serial testing
was performed. The GDS score was scored during a week 9
videoconference and a week 12 in-clinic visit. The Philadelphia
Naming Test (61) short form was scored twice; the maximum
score is 30, and higher scores reflect less aphasia. Form A was
scored during the live week 6 visit; Form B, which assesses 30
different objects, was scored by the therapist 1 week later, during
a videoconference.
Data Analysis
Data analysis used non-parametric statistical testing (JMP 13,
SAS; Cary, NC). Statistical moments are presented as median
(IQR). All analyses were two-tailed, with statistical significance
set at p< 0.05 and no corrections made for multiple comparisons
in this feasibility study. Within-subject changes in performance
over time were analyzed using the Wilcoxon Signed Rank
Test. Comparisons of subject values in weeks 1–6 vs. weeks
7–12 were analyzed using the Wilcoxon Rank Sums Test.
Comparisons of two continuous variable were performed using
the Spearman Rank Correlation Coefficient. For some telerehab-




A total of 15 subjects were screened, of whom 13 were enrolled.
Each was assigned 72 treatment sessions and 18 videoconferences
with a study therapist, distributed over 12 weeks. For all subjects,
the home WiFi network consistently supported TR data uploads
and downloads as well as videoconferences. Of the 13 patients,
nine received concomitant therapy outside of study procedures at
some point during the study: seven at baseline; seven at 6-weeks,
and eight at 12 weeks. There were no adverse events.
Subjects were a median of 61 years old and 4 months post-
stroke at study entry (Table 2); 5 patients were <90 days post-
stroke (range, 37–67 days), 8 patients were ≥90 days (range,
119–1,682), and 4 patients were >1 year post-stroke (range 16–
56 months). Nine subjects were White, 3 Asian, and 1 African-
American. One subject was Hispanic. All subjects had completed
high school, with a median of 2 additional years of education. No
patient had aphasia or spatial neglect.
Therapy Dose and Compliance
Patients completed 50.4 h (33.3–56.7) of TR over the 12 weeks,
and attended a median of 16 (14–18) videoconferences. Patients
initiated the daily TR session (did >5% of assigned minutes) on
79.9% of days, and completed most of the session (did >50% of
assignedminutes) on 65.7% of days. Common reasons for missed
therapy sessions were vacation (55), demands from the patient’s
job (40), scheduling conflicts (32), and illness (22).
Compliance declined across the 12 weeks of therapy.
Comparing weeks 1–6 with weeks 7–12: session initiation
decreased from 86.4 to 73.5% (p < 0.0001; Figure 1A); and
session completion decreased from 76.9 to 54.6% (p < 0.0001;
Figure 1B), i.e., non-compliance doubled in the second 6-week
block. The rate of session completion across the 12 weeks did not
vary in relation to time post-stroke (r = 0.28, p = 0.36), age (r =
0.33, p = 0.27), or baseline scores on the GDS (r = −0.38, p =
0.2), MoCA (r = −0.28, p = 0.35), or UE-FM (r = −0.41, p =
0.17). Although the content and quantity of assigned therapy was
constant over time, subjects completed a median of 61.5 (IQR =
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33–65.8) min/day of therapy during weeks 1–6 vs. 43.6 (2–63.3)
min/day during weeks 7–12 (p < 0.0001). Subjects engaged in
free play after finishing their assigned therapy on 1/5 days during
weeks 1–6 but only 1/16 days during weeks 7–12 (p < 0.0001).
In-clinic Assessments
TRwas associated with significant UEmotor gains. From baseline
pre-therapy to follow-up after 12 weeks of TR therapy, the
TABLE 2 | Patient values at baseline.
Baseline
N 13
Sex 9 M/4 F
Age 61 [52–65.5]
Time post-stroke (days) 129 [52–486]
BMI 26.6 [24.8–32.3]
Systolic blood pressure (mm Hg) 120 [118–134]
Diastolic blood pressure (mm Hg) 75 [72–80]
Hypertension 10 Yes
Hypercholesterolemia 7 Yes
Diabetes mellitus 4 Yes
Atrial fibrillation 2 Yes
Affected side 10 L/3 R
Shoulder pain present at baseline 8 Yes
Handedness 10 R/3 L
Optimization in Primary and Secondary Control scale 5.6 [5.1–6.0]
MOS Social Support Survey* 83 [69–92]
Brief Resilience Scale* 23.5 [22.25–26]
Generalized Anxiety Disorder-7* 3 [0–8.5]
Values are median (IQR).
*Data acquired via the TR system, with no therapist present.
primary endpoint, UE-FM score, changed by 6 (2.5–12.5) points
(p = 0.0005). Most of this change was achieved in the first 6
weeks, as UE-FM score change from baseline to week 6 was 6 (2–
9.5) points (p= 0.0007). From week 6 to week 12, median change
was 1 (−0.5 to 2) point (p = 0.19). The extent of 12-week gains
on the UE-FM scale declined with increasing time post-stroke at
enrollment (r = −0.63, p = 0.02). Similar gains were seen from
baseline to week 12 for change in affected armBox&Blocks score,
with median change of 9 blocks (3.5–17.5) (p = 0.0005). Median
change in unaffected arm Box & Blocks score during this interval
was non-significant [2 blocks (−5 to 4.5) (p= 0.69)].
Findings were similar for the LE. Gait velocity improved by
a median of 0.15 (0.07–0.22) m/s from baseline to week 12 (p =
0.0007). Most of this change was achieved in the first 6 weeks,
where change from baseline was 0.08 (0.02–0.20) m/s (p= 0.007).
Results were more modest for the LE-FM score change, which
was 1 (−0.5 to 5) point (p= 0.065) over 12 weeks.
Several other classes of outcome measure also showed
improvement. Scores on the mRS ranged from 2 to 3 at baseline
and from 1 to 2 at week 12 (change over time, p = 0.03).
This change was accounted for by improved mRS score in 6/13
patients (five with initial score = 3 and one with initial score =
2), 3 of whom were <90 days post-stroke (37–67 days) and 3 of
whom were >90 days post-stroke (4, 5.5, and 56 months post-
stroke) at study enrollment. In addition, the EQ-VAS increased
from baseline to week 12 by a median of 15 (2.5–31), indicating
improved self-rating of health state. Mood (GDS) improved over
time (p= 0.05); note that a GDS score> 5, suggesting depression,
was present in 3 subjects at week 1 and 0 subjects at week 12.
Remote Assessments
There were three types of remote assessments (Table 3). First,
therapist-directed measures during videoconferences captured
behavioral gains. Hand usage, measured using the SIS-hand scale,
FIGURE 1 | Compliance with TR assignments declined during the 12 weeks. (A) During TR weeks 1–6 (days 1–36), there was a decline in TR session initiation
compared to weeks 7–12 (days 37–72), from 86.4 to 73.5% (p < 0.0001). (B) There was a similar decline in in TR session completion, from 76.9 to 54.6%
(p < 0.0001).
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TABLE 3 | Behavioral change after 6 and 12 weeks of treatment.
Baseline After 6 weeks of treatment p∧ After 12 weeks of treatment p∧∧
Arm motor Fugl-Meyer score 46 [42–57] 57 [50–61] 0.0007 59 [52.5–61.5] 0.0005
Box & Blocks score, affected arm 32 [23–42.5] 46 [39–50] 0.0005
Box & Blocks score, unaffected arm 55 [48.5–57] 53 [47.5–61.5] 0.69
Gait velocity [m/sec] 0.94 [0.67–1.09] 0.90 [0.71–1.2] 0.007 1.01 [0.83–1.21] 0.0007
Leg motor Fugl-Meyer score 28 [23.5–29] 27 [26–29.5] 0.48 28 [27–30.5] 0.065
Nottingham sensory score, affected arm 11 [10–11] 11 [11–11] 0.12
Geriatric Depression Scale score 3 [1–5] 1 [0–4] 0.05
Montreal Cognitive Assessment score 27 [24.5–29] 29 [25.5–30] 0.13
Modified Rankin Scale 2 [2–3] 2 [2–2] 0.03
EQ-VAS 75 [52.5–80] 80 [72.5–90] 0.003
Modified Ashworth spasticity scale, elbow flexor 1.5 [0.5–1.5] 1 [0–1.25] 0.11
Stroke Impact Scale-hand* 3.4 [2.7–3.9] 4.0 [3.5–4.8] 0.002
Stroke Impact Scale-ADL* 3.8 [3.1–4.4] 4.2 [4.0–4.5] 0.06
Values are median (IQR); p values are based on Wilcoxon Signed Rank Test for change over time from baseline to ∧6 weeks or baseline to ∧∧12 weeks.
*Data acquired via the TR system, with therapist supervision.
showed significant gains (p= 0.002). Functional status, measured
using the SIS-ADL scale, showed improvement over time that
narrowly missed significance (p = 0.06). Second, therapist-
independent measures (no therapist online when scored) reliably
assessed patient status. Median score on the MOS-SSS was 83
(69–92), indicating strong social support on average. Median
score on the Brief Resilience Scale was 23.5 (22.25–26), indicating
overall good resilience. Median score on the GAD-7 scale was 3
(0–8.5), indicating low anxiety on average. Scores for shoulder
pain were stable from week 1 to week 6, rising slightly, from 0
(0–31) to 9 (0–25) (p = 0.46) on this 100-point visual analog
scale. Fatigue, however, declined significantly from week 1 to
week 6, from 36 (8–61) to 16 (0–43) (p = 0.004). Third, for two
assessments, therapist scores obtained in-clinic were compared to
those obtained during TR. The two sets of GDS scores obtained 3
weeks apart were closely related (r = 0.89, p < 0.0001; Figure 5)
and showed an intraclass correlation coefficient of 0.66; note that
one subject was not available for the week-9 videoconference.
Findings on the Philadelphia Naming Test had a ceiling effect that
limited comparisons, as scores on Form A in-clinic were perfect
in all but two patients and scores on Form B via TR were perfect
in all but three patients.
Augmented Reality Gaming and
Application of Sensors to Real Objects
Augmented reality was successfully incorporated into home-
based TR. The equipment was installed in the home, the AR game
assigned by the therapist, and these were used by patients during
TR (Figure 2). Similarly, an accelerometer could be applied
to various objects by the patient at home (Figure 3), allowing
movement of a real object in a functional way to play a game that
emphasized iADLs.
Daily Study Pill
Consumption of a study pill once/day (Figure 4) was successfully
incorporated into TR sessions. One subject requested not to
have any photos taken. The remaining 12 subjects used their TR
system on 681 days, and took their pill on 619 of these days,
resulting in 90.9% compliance with daily study pill consumption.
The Bluetooth-enabled pill bottle cap worked properly but there
were difficulties keeping its software running at all times in the
background of the TR program.
Automatic Actionable Reports by Email for
Critical Findings
Email-alerts were sent to the PI and to the study coordinator
reliably and with specificity whenever there was (1) a substantial
increase in body or shoulder pain or (2) non-compliance with
therapy for 3 days. During the study, reportable incidents only
occurred in relation to non-compliance.
DISCUSSION
High dose rehabilitation therapy can improve outcomes after
stroke, but this is not provided to many patients. Telehealth
methods have the potential to overcome many of the barriers to
high dose therapy, such as transportation limitations or limited
regional access. In an effort to improve our approach to home-
based TR, the current study aimed to evaluate the feasibility of
several system expansions related to assessment and to treatment.
Enrollees were recruited at wide-ranging times post-stroke,
had overall moderate motor deficits and little sensory deficits,
were highly dedicated to treatment goals, lacked cognitive
deficits, had low anxiety and depression symptoms, had good
social support, and reported high resiliency (Tables 2, 3). In our
prior studies, we relied on a Verizon wireless modem to connect
the patient’s home-based TR system to the internet and thereby
enable communication between the home and the clinic. The
current study found that we can instead rely on the patient’s
personal wireless network, an approach that, when available, has
advantages such as connection speed.
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FIGURE 2 | For the virtual varmint game, a camera under the table pointed at the floor captured live images, including the patient’s paretic foot, that were projected
onto the screen of a tabletop tablet. When patients directed their gaze at the tabletop, they were thus able to see real-time images of their foot movements. A virtual
varmint was introduced into the tablet image, which the patient was able to manipulate with their foot. (A) A virtual image of a varmint is introduced onto the screen of
the tabletop tablet. (B) The patient moves his foot toward the virtual varmint. (C) The patient swats the virtual varmint with his foot, scoring points.
Across the 12 weeks of TR, UE and LEmotor status, functional
status, and quality of life all improved significantly (Table 3),
particularly during the first 6 weeks. These gains occurred as
patients completed a median of 50.4 h/subject of TR. Some of
this improvement might be related to spontaneous post-stroke
recovery. Five of the 13 enrollees were <90 days post-stroke
at enrollment, and so some of their behavioral improvement is
likely attributable to spontaneous recovery; consistent with this,
UE-FM gains declined with greater time post-stroke.
Longer Therapy Duration
Our prior trial (48) evaluated 6 weeks of therapy provided
6 days/week (70-min sessions, 42 h total). Here we aimed to
evaluate a course of TR lasting for twice as long: 12 weeks of
therapy (60-min sessions, 72 h total). This was driven in part by
our review of home-based technologies for stroke rehabilitation
(75), which noted that across 31 studies, most technologies were
evaluated for short time periods. In addition, larger doses of TR
have been reported to result in greater benefit (76).
The rate with which subjects initiated (Figure 1A) and
completed (Figure 1B) TR assignments declined significantly
across the 12 weeks of therapy. During TR weeks 1–6, TR session
completion was 76.9%, lower than the 98.3% value seen during
a 6-week course of telerehabilitation in our 11-site study (48).
Compliance was not related to time post-stroke, age, depression,
cognitive status, or arm motor impairments at baseline, although
the sample size is limited for examining these issues. Several
reasons might account for lower compliance over time seen in
the current study. Functional gains during the first 6 weeks might
have reduced motivation to perform TR thereafter. Patients
might have become bored with some games. During weeks 7–
12, videoconferences were reduced from 3x/week to 1x/week,
due to budgetary constraints, which might have contributed
to the doubling of non-compliance during this period. These
videoconferences were a stimulus for patient accountability,
and so a reduction in their frequency might have adversely
affected compliance. In addition to driving accountability,
videoconferences also foster a relationship between patient and
therapist that might be important to sustained compliance. In a
qualitative study (77) of 13 patients randomized to TR at one site
in our national trial, regular videoconferences with a therapist
were highly rated. Fewer interactions during videoconferences
might produce weaker patient-therapist bonds, contributing
to non-compliance.
Treatment of Both UE and LE Motor
Deficits
This study also examined the feasibility of treating both UE and
LE motor deficits. While not all stroke survivors have motor
deficits in both UE and LE, involvement of both is more common
than is paresis in either alone (78). Despite this, only 2 of the 22
stroke TR trials have targeted both UE and LE deficits (45). The
current study found that exercises and games targeting LE motor
deficits were readily incorporated alongside those targeting UE,
and were associated with significant gains in gait velocity.
Increasing the Functional Relevance of TR
Practice of real life tasks with real objects can increase object
affordance and task ecology and is often incorporated into
constraint induced therapy (51). The TR system is well suited to
adopt this strategy. The current study found that a sensor could
be attached to real objects, providing data that are used to drive
game play that targeted pouring liquids (Figure 3), which is part
of meal preparation, an important iADL.
An additional way to expand the functional relevance of TR
therapy is to incorporate virtual objects that may be impractical
or unsafe in the patient’s home. AR integrates virtual elements
into the real world (54) and was successfully incorporated into
the TR system (Figure 2). AR introduces an additional form of
human-computer interface that can be used to modulate a task’s
cognitive demand (55).
Daily Consumption of a Study Medication
Integrated Into TR
Daily ingestion of a study pill was integrated into the home-
based TR system. Patients were prompted to take a study pill
at the start of each session and did so 90.9% of the days that
they initiated a TR session (Figure 4). Driving patient compliance
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FIGURE 3 | Sensors were attached to real objects to play a game that drives an iADL. The patient grasped an actual water pitcher onto which an accelerometer
(green arrow) was attached magnetically. Accelerometer data were sent to the computer running the TR program. As the subject rotated the hand-held pitcher, the
figure of a pitcher on the video screen moved synchronously. In this way, the subject used a real object to play a game, displayed on the TR computer screen, where
the goal was to fill empty cups to the correct level.
FIGURE 4 | Photographs were used to confirm that the study pill was taken each day as instructed. (A) The patient is seated; arrow indicates cap on the bottle
holding study pills. (B) The patient has removed the pill bottle lid and placed onto the trackpad; arrow indicates the lid. (C) The patient has removed one pill and
placed into her palm; arrow indicates the pill. (D) The patient has taken the pill. (E) The lid has been replaced; arrow indicates the lid.
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FIGURE 5 | GDS scores during a live visit 12 weeks after study entry are
closely related to GDS scores obtained during a TR videoconference 9 weeks
after study entry (r = 0.89, p < 0.0001, n = 12). The intraclass correlation
coefficient was 0.66.
with pill consumption each day might be useful in clinical
practice, e.g., to improve secondary stroke prevention or in
clinical research, e.g., when studying an orally ingested drug that
might promote recovery, particularly since TR enables careful
pairing of behavioral training with pill consumption (79–81).
Additional TR-Based Assessments
TR not only provides an opportunity for remote therapy but
also provides a platform for remotely measuring, both passively
and actively (82), a broad range of human activities (83)
and behavioral and psychological symptoms (84). This can
promote greater independence and quicker access to healthcare
professionals (85). The current results support the feasibility of
using TR tomeasure hand usage (SIS-hand) and functional status
(SIS-ADL). The GDS was validated for depression telescreening
(Figure 5); interestingly, average scores at home were higher
compared to when the same scale was administered in the clinic,
in contradistinction to prior results obtained in a non-stroke
population (86).
We evaluated four assessments that were scored
asynchronously, i.e., by the patient with no therapist supervision,
and all were successfully collected. These include the MOS-SSS,
which indicated strong social support; the Brief Resilience Scale,
which showed overall good resilience; and the GAD-7, which
showed low anxiety scores. In addition, shoulder pain and
fatigue were assessed weekly. Shoulder pain, the most common
adverse event in patients randomized to TR in our prior national
trial (48), was mild and stable over 6 weeks. Patients reported a
significant decline in fatigue over time.
TR-Generated Actionable Reports
A very large amount of data is generated by the TR system.
Efficient approaches are needed to bring the most critically
important findings to the attention of busy clinicians. We
incorporated actionable reports, whereby a clinician is notified
electronically of a critical finding, along with a suggested
response. Electronic notification of critical results has advantages
that include decreased workflow interruptions and more timely
closed-loop communications of key patient data (87). Such
reports are most effective when recommendations presented to
clinicians are clear, explicit, and actionable (88). Such reports
should focus on high quality observations that present critical
new knowledge (89). Communication of critical results is a
national patient safety goal emphasized by the Joint Commission,
and is no less important in stroke recovery. The current pilot
study provides support for actionable results to transmit critical
findings in two categories, pain and treatment compliance.
Strengths and Weaknesses
Strengths of this feasibility study include successful evaluation
of several new expanded TR features related to treatment
and to assessment, including longer-term therapy, addition of
therapy targeting the LE, increased dimensions of assessments,
incorporation of real objects and AR, and introduction of a daily
study pill. There were several key weaknesses, as well. The sample
size was limited. As this was a feasibility study, there was a single
treatment arm and no control group. Some patients might not
have completed spontaneous recovery at study entry, although
the goal was to evaluate new TR features rather than establish
efficacy. The total number of daily limb movements during
TR was not measured, as in our prior studies. No qualitative
study was performed to better understand the perspectives of
patients and caregivers. Current results incompletely generalize,
as enrollees lacked substantial aphasia, neglect, sensory deficits,
depression, and anxiety.
Conclusions
The current study examined the feasibility of adding new
modules to a home-based TR system for patients with stroke.
Some modules were therapy-focused, such as longer duration of
therapy and ingestion of daily study medication, while others
were diagnostic, such as assessments performed by the patient
with no therapist supervision. These results inform future efforts
to develop TR approaches to address the many aspects of treating
patients with stroke.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.
ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by UC Irvine IRB. The patients/participants provided
their written informed consent to participate in this study.
Frontiers in Neurology | www.frontiersin.org 10 February 2021 | Volume 11 | Article 611453
Cramer et al. Expanded Telerehabilitation After Stroke
AUTHOR CONTRIBUTIONS
The study was designed by SC, LD, AM, JS, RA, RZ, AD,WS, and
JH. The study was conducted, the manuscript was written, and
critically revised by all authors.
FUNDING
This work was supported by 17IRG33460393 (American
Heart Association/American Stroke Association) and UL1-
TR001414 (NIH).
REFERENCES
1. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology:
a review of population-based studies of incidence, prevalence, and
case-fatality in the late 20th century. Lancet Neurol. (2003) 2:43–53.
doi: 10.1016/S1474-4422(03)00266-7
2. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson
AP, et al. Heart disease and stroke statistics-2020 update: a report
from the American Heart Association. Circulation. (2020) 141:e139–596.
doi: 10.1161/CIR.0000000000000757
3. Johnston SC, Hauser SL. Neurological disease on the global agenda. Ann
Neurol. (2008) 64:A11–2. doi: 10.1002/ana.21477
4. Krishnamurthi RV, Ikeda T, Feigin VL. Global, regional and country-specific
burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid
haemorrhage: a systematic analysis of the global burden of disease study 2017.
Neuroepidemiology. (2020) 54:171–9. doi: 10.1159/000506396
5. Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, Yatsu
F. The global stroke initiative. Lancet Neurol. (2004) 3:391–3.
doi: 10.1016/S1474-4422(04)00800-2
6. Goldstein L, Adams R, Becker K, Furberg C, Gorelick P, Hademenos G,
et al. Primary prevention of ischemic stroke: a statement for healthcare
professionals from the stroke council of the American Heart Association.
Stroke. (2001) 32:280–99. doi: 10.1161/01.STR.32.1.280
7. Rathore S, Hinn A, Cooper L, Tyroler H, Rosamond W. Characterization
of incident stroke signs and symptoms: findings from the
atherosclerosis risk in communities study. Stroke. (2002) 33:2718–21.
doi: 10.1161/01.STR.0000035286.87503.31
8. Gresham G, Duncan P, Stason W, Adams H, Adelman A, Alexander D, et al.
Post-Stroke Rehabilitation. Rockville, MD: U.S. Department of Health and
Human Services. Public Health Service, Agency for Health Care Policy and
Research (1995).
9. Winstein CJ, Wolf SL, Dromerick AW, Lane CJ, Nelsen MA, Lewthwaite
R, et al. Interdisciplinary comprehensive arm rehabilitation evaluation
(ICARE): a randomized controlled trial protocol. BMC Neurol. (2013) 13:5.
doi: 10.1186/1471-2377-13-5
10. Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC,
et al. Guidelines for adult stroke rehabilitation and recovery: a
guideline for healthcare professionals from the American Heart
Association/American Stroke Association. Stroke. (2016) 47:e98–169.
doi: 10.1161/STR.0000000000000098
11. Stewart JC, Cramer SC. Patient-reported measures provide unique
insights into motor function after stroke. Stroke. (2013) 44:1111–6.
doi: 10.1161/STROKEAHA.111.674671
12. Wyller TB, Sveen U, Sodring KM, Pettersen AM, Bautz-Holter E.
Subjective well-being one year after stroke. Clin Rehabil. (1997) 11:139–45.
doi: 10.1177/026921559701100207
13. Galvin R, Murphy B, Cusack T, Stokes E. The impact of increased duration of
exercise therapy on functional recovery following stroke–what is the evidence?
Top Stroke Rehabil. (2008) 15:365–77. doi: 10.1310/tsr1504-365
14. Galvin R, Cusack T, O’Grady E, Murphy TB, Stokes E. Family-mediated
exercise intervention (FAME): evaluation of a novel form of exercise delivery
after stroke. Stroke. (2011) 42:681–6. doi: 10.1161/STROKEAHA.110.594689
15. Kwakkel G, van Peppen R, Wagenaar RC, Wood Dauphinee
S, Richards C, Ashburn A, et al. Effects of augmented exercise
therapy time after stroke: a meta-analysis. Stroke. (2004) 35:2529–39.
doi: 10.1161/01.STR.0000143153.76460.7d
16. Cauraugh JH, Naik SK, Lodha N, Coombes SA, Summers JJ. Long-
term rehabilitation for chronic stroke arm movements: a randomized
controlled trial. Clin Rehabil. (2011) 25:1086–96. doi: 10.1177/02692155114
10580
17. Veerbeek JM, van Wegen E, van Peppen R, van der Wees PJ, Hendriks
E, Rietberg M, et al. What is the evidence for physical therapy poststroke?
A systematic review and meta-analysis. PLoS ONE. (2014) 9:e87987.
doi: 10.1371/journal.pone.0087987
18. Lohse KR, Lang CE, Boyd LA. Is more better? Using metadata to explore
dose-response relationships in stroke rehabilitation. Stroke. (2014) 45:2053–8.
doi: 10.1161/STROKEAHA.114.004695
19. Van Stan JH, Dijkers MP, Whyte J, Hart T, Turkstra LS, Zanca JM, et al. The
rehabilitation treatment specification system: implications for improvements
in research design, reporting, replication, and synthesis. Arch Phys Med
Rehabil. (2019) 100:146–55. doi: 10.1016/j.apmr.2018.09.112
20. Outpatient Service Trialists. Rehabilitation therapy services for stroke patients
living at home: systematic review of randomised trials. Lancet. (2004)
363:352–6. doi: 10.1016/S0140-6736(04)15434-2
21. Cramer SC, Sur M, Dobkin BH, O’Brien C, Sanger TD, Trojanowski JQ, etal.
Harnessing neuroplasticity for clinical applications. Brain. (2011) 134:1591–
609. doi: 10.1093/brain/awr039
22. Woldag H, Hummelsheim H. Evidence-based physiotherapeutic concepts for
improving arm and hand function in stroke patients: a review. J Neurol. (2002)
249:518–28. doi: 10.1007/s004150200058
23. Takahashi CD, Der-Yeghiaian L, Le V, Motiwala RR, Cramer SC.
Robot-based hand motor therapy after stroke. Brain. (2008) 131:425–37.
doi: 10.1093/brain/awm311
24. Kleim JA, Jones TA. Principles of experience-dependent neural plasticity:
implications for rehabilitation after brain damage. J Speech Lang Hear Res.
(2008) 51:S225–39. doi: 10.1044/1092-4388(2008/018)
25. Cramer SC, Riley JD. Neuroplasticity and brain repair after stroke. Curr Opin
Neurol. (2008) 21:76–82. doi: 10.1097/WCO.0b013e3282f36cb6
26. Bloem BR, Dorsey ER, Okun MS. The coronavirus disease 2019 crisis as
catalyst for telemedicine for chronic neurological disorders. Jama Neurol.
(2020) 77:927–8. doi: 10.1001/jamaneurol.2020.1452
27. Richmond T, Peterson C, Cason J, Billings M, Terrell EA, Lee
ACW, et al. American Telemedicine Association’s principles for
delivering telerehabilitation services. Int J Telerehabil. (2017) 9:63–8.
doi: 10.5195/IJT.2017.6232
28. Demiris G, Shigaki CL, Schopp LH. An evaluation framework for a rural
home-based telerehabilitation network. J Med Syst. (2005) 29:595–603.
doi: 10.1007/s10916-005-6127-z
29. Coleman JJ, Frymark T, Franceschini NM, Theodoros DG. Assessment and
treatment of cognition and communication skills in adults with acquired brain
injury via telepractice: a systematic review. Am J Speech Lang Pathol. (2015)
24:295–315. doi: 10.1044/2015_AJSLP-14-0028
30. Theodoros DG. Telerehabilitation for service delivery in speech-language
pathology. J Telemed Telecare. (2008) 14:221–4. doi: 10.1258/jtt.2007.007044
31. Hill AJ, Theodoros D, Russell T, Ward E. Using telerehabilitation to assess
apraxia of speech in adults. Int J Lang Commun Disord. (2009) 44:731–47.
doi: 10.1080/13682820802350537
32. Sarfo FS, Ulasavets U, Opare-Sem OK, Ovbiagele B. Tele-rehabilitation after
stroke: an updated systematic review of the literature. J Stroke Cerebrovasc Dis.
(2018) 27:2306–18. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.013
33. HillsdonM, ThorogoodM. A systematic review of physical activity promotion
strategies. Br J Sports Med. (1996) 30:84–9. doi: 10.1136/bjsm.30.2.84
34. Coscia M, Wessel MJ, Chaudary U, Millan JDR, Micera S, Guggisberg A, et al.
Neurotechnology-aided interventions for upper limb motor rehabilitation
in severe chronic stroke. Brain. (2019) 142:2182–97. doi: 10.1093/brain/
awz181
Frontiers in Neurology | www.frontiersin.org 11 February 2021 | Volume 11 | Article 611453
Cramer et al. Expanded Telerehabilitation After Stroke
35. Baranowski T, Buday R, Thompson DI, Baranowski J. Playing for real: video
games and stories for health-related behavior change. Am J Prev Med. (2008)
34:74–82. doi: 10.1016/j.amepre.2007.09.027
36. Brox, E, Fernandez-Luque L, Tøllefsen T. Healthy gaming – video
game design to promote health. Appl Clin Inform. (2011) 2:128–42.
doi: 10.4338/ACI-2010-10-R-0060
37. Hansen MM. Versatile, immersive, creative and dynamic virtual 3-D
healthcare learning environments: a review of the literature. J Med Internet
Res. (2008) 10:e26. doi: 10.2196/jmir.1051
38. Lieberman D. Designing serious games for learning and health in informal
and formal settings. In: Ritterfeld M, Vorderer P, editors. Serious Games:
Mechanisms and Effects. New York, NY: Routledge (2009). p. 117–30.
39. Thompson D, Baranowski T, Buday R, Baranowski J, Thompson V, Jago
R, et al. Serious video games for health how behavioral science guided the
development of a serious video game. Simul Gaming. (2010) 41:587–606.
doi: 10.1177/1046878108328087
40. Robert Wood Johnson Foundation. Advancing the Field of Health Games: A
Progress Report on Health Games Research. Robert wood johnson foundation
(2011). Available online at: http://www.rwjf.org/content/rwjf/en/research-
publications/find-rwjf-research/2011/03/advancing-the-field-of-health-
games.html (accssed November 21, 2020).
41. Przybylski A, Rigby C, Ryan R. A motivational model of video game
engagement. Rev Gen Psychol. (2010) 14:154–66. doi: 10.1037/a0019440
42. Duncan PW, Horner RD, Reker DM, Samsa GP, Hoenig H, Hamilton B, et al.
Adherence to postacute rehabilitation guidelines is associated with functional
recovery in stroke. Stroke. (2002) 33:167–77. doi: 10.1161/hs0102.101014
43. Jurkiewicz MT, Marzolini S, Oh P. Adherence to a home-based exercise
program for individuals after stroke. Top Stroke Rehabil. (2011) 18:277–84.
doi: 10.1310/tsr1803-277
44. Touillet A, Guesdon H, Bosser G, Beis JM, Paysant J. Assessment of
compliance with prescribed activity by hemiplegic stroke patients after an
exercise programme and physical activity education. Ann Phys Rehabil Med.
(2010) 53:250–7, 257–65. doi: 10.1016/j.rehab.2010.03.005
45. Laver KE, Adey-Wakeling Z, Crotty M, Lannin NA, George S, Sherrington
C. Telerehabilitation services for stroke. Cochrane Database Syst Rev. (2020)
1:CD010255. doi: 10.1002/14651858.CD010255.pub3
46. Dodakian L, McKenzie AL, Le V, See J, Pearson-Fuhrhop K, Burke
Quinlan E, et al. A home-based telerehabilitation program for
patients with stroke. Neurorehabil Neural Repair. (2017) 31:923–33.
doi: 10.1177/1545968317733818
47. Zhou RJ, Hondori HM, Khademi M, Cassidy JM, Wu KM, Yang DZ,
et al. Predicting gains with visuospatial training after stroke using an
EEG measure of frontoparietal circuit function. Front Neurol. (2018) 9:597.
doi: 10.3389/fneur.2018.00597
48. Cramer SC, Dodakian L, Le V, See J, Augsburger R, McKenzie A, et al.
Efficacy of home-based telerehabilitation vs in-clinic therapy for adults
after stroke: a randomized clinical trial. JAMA Neurol. (2019) 76:1079–87.
doi: 10.1001/jamaneurol.2019.1604
49. Jorgensen H, Nakayama H, Raaschou H, Vive-Larsen J, Stoier M, Olsen
T. Outcome and time course of recovery in stroke. Part II: time course
of recovery. The Copenhagen stroke study. Arch Phys Med Rehabil. (1995)
76:406–12. doi: 10.1016/S0003-9993(95)80568-0
50. de Havenon A, Tirschwell D, Heitsch L, Cramer S, Braun R, Cole J, et al.
Variability of the modified Rankin scale score between day 90 and 1 year after
ischemic stroke. Neurol Clin Pract. (2020).
51. Wolf SL, Winstein CJ, Miller JP, Taub E, Uswatte G, Morris D, et al. Effect
of constraint-induced movement therapy on upper extremity function 3 to
9 months after stroke: the EXCITE randomized clinical trial. JAMA. (2006)
296:2095–104. doi: 10.1001/jama.296.17.2095
52. Wirth LA, Breiner J. Jeopardy: using a familiar game to teach health. J Sch
Health. (1997) 67:71–4. doi: 10.1111/j.1746-1561.1997.tb06304.x
53. Webb TP, Simpson D, Denson S, Duthie E Jr. Gaming used as an informal
instructional technique: effects on learner knowledge and satisfaction. J Surg
Educ. (2012) 69:330–4. doi: 10.1016/j.jsurg.2011.10.002
54. Baus O, Bouchard S. Moving from virtual reality exposure-based therapy to
augmented reality exposure-based therapy: a review. Front Hum Neurosci.
(2014) 8:112. doi: 10.3389/fnhum.2014.00112
55. Mousavi Hondori H, Khademi M, Dodakian L, McKenzie A, Lopes
CV, Cramer SC. Choice of human-computer interaction mode in
stroke rehabilitation. Neurorehabil Neural Repair. (2016) 30:258–65.
doi: 10.1177/1545968315593805
56. Fugl-Meyer A, Jaasko L, Leyman I, Olsson S, S S. The post-stroke hemiplegic
patient: a method for evaluation of physical performance. Scand J Rehabil
Med. (1975) 7:13–31.
57. See J, Dodakian L, Chou C, Chan V, McKenzie A, Reinkensmeyer DJ,
et al. A standardized approach to the Fugl-Meyer assessment and its
implications for clinical trials. Neurorehabil Neural Repair. (2013) 27:732–41.
doi: 10.1177/1545968313491000
58. Mathiowetz V, Volland G, Kashman N, Weber K. Adult norms for the box
and block test of manual dexterity. Am J Occup Ther. (1985) 39:386–91.
doi: 10.5014/ajot.39.6.386
59. Bohannon RW. Comfortable and maximum walking speed of adults aged
20-79 years: reference values and determinants. Age Ageing. (1997) 26:15–9.
doi: 10.1093/ageing/26.1.15
60. Oldfield R. The assessment and analysis of handedness:
the Edinburgh inventory. Neuropsychologia. (1971) 9:97–113.
doi: 10.1016/0028-3932(71)90067-4
61. Roach A, Schwartz MF, Martin N, Grewal R, Brecher A. The Philadelphia
naming test: scoring and rationale. Clin Aphasiol. (1996) 24:121–33.
doi: 10.1037/t56477-000
62. Albert ML. A simple test of visual neglect. Neurology. (1973) 23:658–64.
doi: 10.1212/WNL.23.6.658
63. Podury A, Raefsky S, Dodakian L,McCafferty L, Le V,McKenzie A, et al. Social
network structure is related to functional improvement from home-based
telerehabilitation after stroke. Front Neurol. (in press).
64. Heckhausen J, Schulz R, Wrosch C. Developmental regulation in adulthood:
optimization in primary and secondary control–a multiscale questionnaire
(OPS-scales). In: Heckhausen J, Dweck C, editors. Motivation and Self-
Regulation Across the Life Span. New York, NY: Cambridge University (1998).
p. 50–77.
65. Lincoln N, Jackson J, Adams S. Reliability and revision of the Nottingham
sensory assessment for stroke patients. Physiotherapy. (1998) 84:358–65.
doi: 10.1016/S0031-9406(05)61454-X
66. Agrell B, Dehlin O. Comparison of six depression rating scales in geriatric
stroke patients. Stroke. (1989) 20:1190–4. doi: 10.1161/01.STR.20.9.1190
67. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V,
Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening
tool for mild cognitive impairment. J Am Geriatr Soc. (2005) 53:695–9.
doi: 10.1111/j.1532-5415.2005.53221.x
68. Broderick JP, Adeoye O, Elm J. Evolution of the modified Rankin
scale and its use in future stroke trials. Stroke. (2017) 48:2007–12.
doi: 10.1161/STROKEAHA.117.017866
69. Rabin R, de Charro F. Eq-5d: a measure of health status from the EuroQoL
group. Ann Med. (2001) 33:337–43. doi: 10.3109/07853890109002087
70. Bohannon R, Smith M. Interrater reliability of a modified Ashworth scale of
muscle spasticity. Phys Ther. (1987) 67:206–7. doi: 10.1093/ptj/67.2.206
71. Duncan P, Wallace D, Lai S, Johnson D, Embretson S, Laster L. The stroke
impact scale version 2.0. Evaluation of reliability, validity, and sensitivity to
change. Stroke. (1999) 30:2131–40. doi: 10.1161/01.STR.30.10.2131
72. Sherbourne CD, Stewart AL. The mos social support survey. Soc Sci Med.
(1991) 32:705–14. doi: 10.1016/0277-9536(91)90150-B
73. Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief
resilience scale: assessing the ability to bounce back. Int J Behav Med. (2008)
15:194–200. doi: 10.1080/10705500802222972
74. Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing
generalized anxiety disorder - the GAD-7. Arch Intern Med. (2006) 166:1092–
7. doi: 10.1001/archinte.166.10.1092
75. Chen Y, Abel KT, Janecek JT, Chen Y, Zheng K, Cramer SC. Home-based
technologies for stroke rehabilitation: a systematic review. Int J Med Inform.
(2019) 123:11–22. doi: 10.1016/j.ijmedinf.2018.12.001
76. Jansen-Kosterink S, In ’t Veld RH, Hermens H, Vollenbroek-Hutten M.
A telemedicine service as partial replacement of face-to-face physical
rehabilitation: the relevance of use. Telemed J E Health. (2015) 21:808–13.
doi: 10.1089/tmj.2014.0173
Frontiers in Neurology | www.frontiersin.org 12 February 2021 | Volume 11 | Article 611453
Cramer et al. Expanded Telerehabilitation After Stroke
77. Chen Y, Chen Y, Zheng K, Dodakian L, See J, Zhou R, et al. A
qualitative study on user acceptance of a home-based stroke telerehabilitation
system. Top Stroke Rehabil. (2020) 27:81–92. doi: 10.1080/10749357.2019.
1683792
78. de Freitas GR, Devuyst G, vanMelle G, Bogousslavsky J.Motor strokes sparing
the leg: different lesions and causes. Arch Neurol Chicago. (2000) 57:513–8.
doi: 10.1001/archneur.57.4.513
79. Feeney D, Gonzalez A, Law W. Amphetamine, halperidol, and experience
interact to affect the rate of recovery after motor cortex injury. Science. (1982)
217:855–7. doi: 10.1126/science.7100929
80. Fang PC, Barbay S, Plautz EJ, Hoover E, Strittmatter SM, Nudo RJ.
Combination of NEP 1-40 treatment and motor training enhances behavioral
recovery after a focal cortical infarct in rats. Stroke. (2009) 41:544–9.
doi: 10.1161/STROKEAHA.109.572073
81. Jeffers MS, Corbett D. Synergistic effects of enriched environment
and task-specific reach training on poststroke recovery of motor
function. Stroke. (2018) 49:1496–503. doi: 10.1161/STROKEAHA.118.
020814
82. Choi YK, Lazar A, Demiris G, Thompson HJ. Emerging smart home
technologies to facilitate engaging with aging. J Gerontol Nurs. (2019) 45:41–8.
doi: 10.3928/00989134-20191105-06
83. Sanchez-Comas A, Synnes K, Hallberg J. Hardware for recognition of human
activities: a review of smart home and aal related technologies. Sensors. (2020)
20:4227. doi: 10.3390/s20154227
84. Husebo BS, Heintz HL, Berge LI, Owoyemi P, Rahman AT, Vahia IV. Sensing
technology to monitor behavioral and psychological symptoms and to assess
treatment response in people with dementia. A systematic review. Front
Pharmacol. (2019) 10:1699. doi: 10.3389/fphar.2019.01699
85. Sapci AH, Sapci HA. Innovative assisted living tools, remote monitoring
technologies, artificial intelligence-driven solutions, and robotic systems
for aging societies: systematic review. JMIR Aging. (2019) 2:e15429.
doi: 10.2196/15429
86. Hansen CH, Walker J, Thekkumpurath P, Kleiboer A, Beale C,
Sawhney A, et al. Screening medical patients for distress and
depression: does measurement in the clinic prior to the consultation
overestimate distress measured at home? Psychol Med. (2013) 43:2121–8.
doi: 10.1017/S0033291712002930
87. Lacson R, Prevedello LM, Andriole KP, O’Connor SD, Roy C, Gandhi
T, et al. Four-year impact of an alert notification system on closed-loop
communication of critical test results.AJR Am J Roentgenol. (2014) 203:933–8.
doi: 10.2214/AJR.14.13064
88. Sahni VA, Khorasani R. The actionable imaging report. Abdom Radiol. (2016)
41:429–43. doi: 10.1007/s00261-016-0679-x
89. Ash JS, Sittig DF, Campbell EM, Guappone KP, Dykstra RH. Some unintended
consequences of clinical decision support systems. AMIA Annu Symp Proc.
(2007) 2007:26–30.
Conflict of Interest: SC has served as a consultant for Constant Therapeutics,
MicroTransponder, Neurolutions, SanBio, Stemedica, Fujifilm Toyama Chemical
Co., NeuExcell, Medtronic, and TRCare. AD is an expert witness for Neuro
Consults, LLC. LD, VL, JS, and RA are consultants for TRCare.
The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Copyright © 2021 Cramer, Dodakian, Le, McKenzie, See, Augsburger, Zhou,
Raefsky, Nguyen, Vanderschelden, Wong, Bandak, Nazarzai, Dhand, Scacchi and
Heckhausen. This is an open-access article distributed under the terms of the Creative
Commons Attribution License (CC BY). The use, distribution or reproduction in
other forums is permitted, provided the original author(s) and the copyright owner(s)
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Neurology | www.frontiersin.org 13 February 2021 | Volume 11 | Article 611453
